MSJ-100 Index
1,036.65
Signal breadth
4 Bullish 93 Neutral 3 Bearish Avg confidence 6.16 / 10
View full MSJ-100 ↗
CL
Colgate-Palmolive Company
Consumer Staples · NYSE: CL · MSJ-100
$91.03
▼ $2.18  (▼2.34%) today
After-hours: $92.00  ▲ 1.07%
Headquarters
New York, NY
Employees
33,600
Founded
1806
CEO
Mr. Noel R. Wallace
Incorporated
Delaware
Fiscal Year End
December
Analyst price target range Free
Avg target $96.35
$91 now
Bear $80 Avg $96 Bull $105
Price history Free
Volume
3.77M
Avg volume
5.34M
Open
$92.95
Day high / low
$93.06 / $91.02
Market cap
$72.8B
About this company
Free
Colgate-Palmolive Company is a global consumer products company focused on reimagining a healthier future for people, pets, and the planet. It operates in two main segments: Oral, Personal and Home Care, offering products like toothpaste, soap, and household cleaners; and Pet Nutrition, providing specialty pet food for dogs and cats. The company holds leadership positions in several of these categories worldwide.
Business segments
10-K
North America Latin America Europe Asia Pacific Africa/Eurasia Pet Nutrition
Recent News
Loading news...
Investor day:
Intel
Free
Jun 03, 2026Neutral
Key metrics
Forward guidance
Notable Q&A
Surprise items
Q1 2026 (May 01, 2026) · Neutral Q1 2026 (Apr 27, 2026) · Confident
Fundamentals
Signal
52-week high / low
$99.33 / $74.55
Forward P/E
22.5×
Trailing 35.3×
Dividend
$2.12 / share
Yield 2.27%
Analysts covering
20
Avg target $96.35
Beta
0.32
vs. S&P 500
Short interest
2.4%
Float shorted
Buy
62%
Hold
33%
Sell
5%
Wall Street consensus — sourced weekly via public disclosures
Analyst coverage data sourced from public filings. Xavier analyst thesis summary available after weekly Perplexity scan completes.
Financial summary — Gemini analysis
Signal
Revenue
$20,382 million
1.4% YoY
Operating margin
16.2%
Net income
$2,132 million
Free cash flow
$3,634 million
Dividend / share
$2.08
Total debt
$7,986 million
Cash: $1,288 million
CapEx guidance
approximately 3.0% of Net sales
Earnings quality: HIGH
Recurring revenue:100%
Cash conversion:2.0x
Non-recurring items: Goodwill and intangible assets impairment charges related to skin health business, ERISA litigation matter charge, Strategic Growth and Productivity Program charges, Acquisition-related costs
Source: SEC 10-K filing analyzed by Gemini 2.5 Flash · 2026-02-23
Xavier sector view:
Consumer Staples
See journal
View Consumer Staples journal ↗
Xavier's signal
NEUTRAL
Signal
Confidence 6.2 / 10  ·  100% model agreement  ·  Scheduled Jun 07, 2026
CL bounced 4.1% today from ~$85 to $88.58 on no fresh fundamental catalyst — the Q1 2026 beat was reported May 1 and is fully a month stale. The stock is trading at 34x TTM P/E with only 2.9% organic sales growth, negative earnings growth year-over-year on a GAAP basis, a downward-revised gross margin outlook due to tariff and raw material cost inflation, and persistent North America volume weakness (-3.2%). At $88.58, CL sits only ~8% below analyst consensus of $95.84, leaving limited upside for a stock with decelerating fundamentals in a neutral-to-bearish macro regime.
Strongest bull case
Goldman Sachs raised its price target to $100 with a Buy rating post-Q1, and a Rothschild upgrade to Buy at $100 signals institutional momentum; the stock is also ~11% below its 52-week high with a low beta (0.32), offering defensive appeal if macro deteriorates further.
Strongest bear case
CL revised gross profit margin guidance downward for full-year 2026 due to tariff and raw material cost inflation, North America volumes declined 3.2% in Q1, GAAP EPS fell YoY, and insiders have made zero open-market purchases while the CFO and COO have sold ~$14M in shares over the past six months — a consistent insider distribution signal.
What the market may be missing
Today's 4.1% single-day pop appears momentum-driven and sentiment-based (leadership appointment news, AI-generated analysis) rather than tied to a new fundamental catalyst; the market may be underweighting the gross margin guide-down and the structural North America volume erosion as price-sensitive consumers continue trading down — a risk that will resurface at Q2 earnings.
Model breakdown
Signal
Atlas (Claude) — NEUTRAL
Meridian (GPT-4) — NEUTRAL
Grayline (Grok) — NEUTRAL
Vantage (Gemini) — NEUTRAL
msj100_CL_20260607T023001Z
Peer comparison
Signal
CL
current
$91.03 ▼2.3%
KR
NEUTRAL
$60.54
PM
NEUTRAL
$181.62
COST
NEUTRAL
$916.25
KO
NEUTRAL
$83.49
Recent SEC filings
Signal
LOG
4 — 2026-07-02
View filing on SEC EDGAR ↗
LOG
4 — 2026-07-02
View filing on SEC EDGAR ↗
LOG
4 — 2026-07-02
View filing on SEC EDGAR ↗
LOG
4 — 2026-06-17
View filing on SEC EDGAR ↗
LOG
4 — 2026-05-18
View filing on SEC EDGAR ↗
CEO scorecard — Noel Wallace
Signal summary
Full detail Pro
NW
Noel Wallace
Chairman, President and Chief Executive Officer · Colgate-Palmolive Company
CEO since 2019
Total compensation
$16,478,196 ▼ 9.6% YoY
Prior year: $18,234,864
Pay vs performance
Aligned
Board assessment
Say-on-pay approval
91%
Shareholder vote
Board independence
9/10 (90%)
Diversity: 50% (4 women)
Base salary$1,500,000
Bonus / incentive
Stock awards$8,005,152
Executive appearances
Intel
Free
InterviewMay 04, 2026
Media That Matters Weekly Roundup Source ↗
Mr. Noel R. Wallace (CEO) · Optimove
During the recent earnings call, Wallace discussed evolving marketing strategies amid industry changes. He stressed the importance of being fluid and dynamic in brand management to drive success. The comments signal a focus on agility in response to
“"very fluid and dynamic” in how brands ...”
Investor DayMay 01, 2026
Colgate-Palmolive Q1 2026 Earnings Call Source ↗
Mr. Noel R. Wallace (CEO) · Colgate-Palmolive Company
Noel Wallace commented on the company's strong quarterly performance after beating earnings estimates. He highlighted expectations of volatile macroeconomic conditions and slower category growth persisting through 2026. Wallace emphasized the need fo
“"volatile macroeconomic conditions and slower category growth to continue in 2026"”
CEO letter to shareholders
Signal
Full letter Pro
Noel Wallace 2025 Annual Report OPTIMISTIC

Dear Colgate-Palmolive Shareholders

Our 2025 performance highlights the resilience of our business model and the strength of our brands. In an operating environment characterized by consumer uncertainty and a global slowdown in category growth, Colgate-Palmolive people operated with determination and focus. We delivered net sales growth, organic sales growth and, on a Base Business basis, increases in gross profit and earnings per share, while generating record operating cash flow to invest in the business and drive total shareholder return. Net sales grew 1.4%; organic sales* also grew 1.4%, on top of strong 7.4% organic sales growth in 2024, led by strength in oral care and pet nutrition, excluding private label as we have exited that non-strategic business. We strengthened our balance sheet and our Board of Directors authorized an increase in the quarterly cash dividend. This was our 63rd consecutive year of dividend increases and our 131st consecutive year paying a dividend.

Despite the many challenges we faced, including sluggish category growth, significant raw material inflation and the impact of incremental tariffs, our strategy is working and delivering strong performance. We have grown our company significantly over the last five years, driving consistent top and bottom-line growth as we look to deliver peer-leading total shareholder return. While we expect the difficult operating environment and slower category growth to continue in the short term, the fundamentals of our business-healthy brands, strong market shares and a diverse global footprint-position us well to deliver peer-leading performance in the long term.

Launching Our 2030 Strategy

2025 marked a pivotal moment for our company as we completed our 2025 strategic plan and introduced our 2030 strategy to the entire organization. Our 2025 strategy drove significant progress, adding $5 billion in net sales. Our 2030 strategy does not call for wholesale changes; rather, we are building on the strong base we created in the 2025 plan to accelerate the rate of change as we adapt to a more complex and dynamic environment. Our 2030 strategy focuses resources on the areas that will deliver the greatest value, including the following key pillars: leveraging the global reach and penetration of our brands; building the incremental benefit of superior, science-based innovation supported by an agile and resilient supply chain; harnessing the power of best-in-class omni-channel demand generation; leading in capabilities like data, analytics and artificial intelligence (AI) and evolving our high-impact, inclusive culture.

Accelerating Science-Led Innovation

Innovation remains a key priority for our company. Over the last five years, we increased our percentage of sales from innovation by nearly 600 basis points, but we believe we need to step that up further. To accelerate our innovation, we are focusing on people-centric insights, utilizing new innovation models to accelerate discovery and incubation and scaling our innovation efficiently across markets. We are deploying proprietary AI tools to analyze deep consumer insights and generate new concepts, images and copy. We are even utilizing "digital consumer twin" panels to test and validate ideas rapidly, giving us a probability of success score before a product ever hits the shelf. This approach allows us to test, iterate and refine products faster than ever as we focus on delivering perceivable superiority with innovations that solve real problems and create value.

We are seeing the success of this approach across our portfolio. In Europe, our elmex franchise is driving record toothpaste market shares with premium, science-driven offerings in the therapeutic oral care segment. In Asia Pacific, Colgate Optic White Purple toothpaste and serum is fueling growth in the whitening segment. In Pet Nutrition, Hill's continues to outperform the category by staying disciplined and true to its science-based positioning, gaining share in key fast-growing segments like cat and wet pet food. Moving forward, we will continue to invest to accelerate innovation, particularly in geographies like the U.S. and key emerging markets.

Driving Omni-Channel Demand Generation

A central pillar of our 2030 strategy is a shift toward what we call omni-channel demand generation, or ODG. The days of relying on television networks and 30 second commercials are far in the past; today, we must understand the "moments that matter" in the path to purchase journey where consumers are discovering and shopping for products both offline and online, often simultaneously.

ODG requires us to behave and process inputs differently to execute more effectively on the ground. We need to seamlessly integrate our commercial spend across the organization to ensure our communication and creative content truly address consumer needs to drive awareness, consideration, purchase and loyalty. As part of this effort, we are leveraging AI and working with our agency partners to create a global content supply chain that allows us to iterate creative assets efficiently, satisfying the high-speed, multi-format requirements of today's digital landscape.

Leading in Data, Analytics and AI

A critical enabler of our 2030 strategy is further enhancing our use of data and technology. Over the course of our 2025 strategy, we have built and scaled foundational capabilities in digital, data and analytics. A great example of this is how we are advancing our revenue growth management capabilities. We have moved from descriptive analytics to predictive models. This advanced technology allows us to ingest billions of data points, from volume and sales to margin inputs, and receive recommendations in minutes on how to optimize pricing and promotion. This shift allows us to make smarter, faster decisions that drive value for both Colgate-Palmolive and our retail partners.

Now, under our 2030 strategy, we are integrating AI across our enterprise as a transformative driver of growth and productivity. AI will enable our teams to accelerate our innovation discovery and testing and provide the ability to generate on-brand content at scale to fuel our ODG initiatives. On the efficiency side, we have deployed advanced AI tools to the entire organization to upskill the team and allow them to create new use cases to drive better outcomes in every function. We will also seek to disrupt our own legacy processes and reconstruct them using the power of AI tools, with humans in the loop, to drive enterprise value.

Strategic Growth and Productivity Program

To deliver the productivity and efficiencies necessary to drive future growth, support our 2030 strategy and drive margin expansion, we announced a new productivity program, the Strategic Growth and Productivity Program (SGPP), in 2025. This program is in addition to our ongoing funding-the-growth productivity initiatives. The SGPP is a catalyst that will help us optimize our global supply chain and simplify and streamline our organizational structure to drive effectiveness in areas like innovation, ODG, AI, data and analytics. To succeed in today's omni-channel environment, we are organizing ourselves differently for truly integrated collaboration as we work to deliver the right messages to the right people at the right time. Importantly, the SGPP also provides the funding to invest back into the business, to support our brands and further advance the capabilities I have outlined. By optimizing our organization today, we are securing the resources necessary to drive sustainable, profitable growth longer term.

Reimagining a Healthier Future for All

As we advance our financial and strategic goals, we remain united by our purpose: Colgate-Palmolive is a caring, innovative growth company that is reimagining a healthier future for all people, their pets and our planet. Our commitment to sustainability and social impact is integrated into our business strategy with a focus on value creation and resilience for the long term. We have evolved and streamlined our Sustainability & Social Impact Strategy with fewer, more measurable key targets designed to drive value, while remaining focused on three areas where we lead: oral health with our Colgate Bright Smiles, Bright Futures program; eliminating plastic waste as we continue our journey to make all toothpaste tubes recyclable; and our impact on climate change through our net zero commitments.

We are excited about the journey ahead. We have a clear strategy, a clear purpose and a high-impact inclusive culture aligned behind our 2030 priorities. I would like to thank all Colgate-Palmolive people around the world for their energy, resilience and unwavering commitment to achieving our goals, and express appreciation for our consumers, customers, suppliers, shareholders and Board of Directors.

We are operating from a position of strength, and we are confident that the changes we are making should enable us to deliver consistent, compounded earnings per share growth and drive value for all our stakeholders in 2026 and beyond.

Sincerely,

Noel Wallace
Chairman, President and Chief Executive Officer

Xavier analysis
The CEO expresses confidence in the business model, brand strength, and strategic direction, highlighting resilience and peer-leading performance despite acknowledging a challenging operating environment.
Strategic themes by emphasis
#1Science-Led Innovation
#2Overall Performance & Future Outlook
#3Omni-Channel Demand Generation (ODG)
#4Leading in Data, Analytics and AI
#5Reimagining a Healthier Future for All (Sustainability & Purpose)
#6Launching Our 2030 Strategy
9 named projects & initiatives
2025 strategic plan, 2030 strategy, Colgate Optic White Purple toothpaste and serum, Hill's Science Diet, Hill's Prescription Diet, Prime100 +3 more
4 product, 3 other, 2 restructuring
Forward-looking statements
7 total: 0 quantified, 6 directional, 1 vague
Capital allocation priority
Investment in the business (organic growth, innovation, capabilities) → Dividends → Driving total shareholder return
Key quotes
“Our 2025 performance highlights the resilience of our business model and the strength of our brands.”
Sets an initial optimistic and confident tone, emphasizing the company's core strengths in a challenging environment.
“Our 2030 strategy does not call for wholesale changes; rather, we are building on the strong base we created in the 2025 plan to accelerate the rate of change as we adapt to a more complex and dynamic”
Indicates strategic continuity and evolution rather than a drastic overhaul, suggesting a confident and adaptive approach to future challenges.
View 2025 Annual Report (PDF) →2 letters on file (2025, 2024) · Full history with Pro
Executive compensation
Signal
NameTitleTotal compensation
Stanley J. Sutula IIIChief Financial Officer$5,664,299
Jennifer M. DanielsChief Legal Officer and Secretary$3,770,777
Shane GrantChief Operating Officer, Americas$11,924,112
Panagiotis TsourapasChief Operating Officer, Eur., APac, Afr/Eur, Skin and Global Cust. Dev.$4,079,561
Source: DEF 14A proxy statement · 2026-03-25
Governance
Pro
Dual-class shares: No
Clawback policy: Yes
Stock ownership req.: Yes
Shareholder proposals
Remove DEI from Board Candidate Considerations
AGAINST
Pending
Independent Board Chairman
AGAINST
Pending
Debt intelligence
Pro
5 debt instruments · 6 unique covenants
54.74x
Debt / Equity
12.1x
Interest coverage
1.7x
Net Debt / EBITDA
$6.6B
Net debt
48%
Debt / Assets
Credit facilities & debt instruments
Revolver $3,000,000,000
FIVE YEAR CREDIT AGREEMENT
Matures 2026-08-20 · Filed 2021-10-29
Floating · SOFR | LIBOR | EURIBOR | Fed Funds | Prime
Unsecured
Revolver
364-DAY CREDIT AGREEMENT
Matures 2022-08-20 · Filed 2020-10-30
Floating · LIBOR | EURIBO | Federal Funds | Prime
Unsecured. Section 5.02(a) implies the facility is unsecured, requiring Advances to be equally and ratably secured if certain Liens are created on Restricted Property.
Credit
364-DAY CREDIT AGREEMENT
Matures 2020-08-21 · Filed 2019-11-01
Floating · Base Rate | Eurocurrency Rate (Eurodollar Rate | EURIBO Rate)
Unsecured. However, if the Borrower or any Principal Domestic Subsidiary creates a Lien on any Restricted Property to secure other indebtedness (not otherwise excluded), the Advances must be directly secured by such Lien equally and ratably with (or prior to) such other indebtedness.
Revolver $2,650,000,000
FIVE YEAR CREDIT AGREEMENT
Matures 2023-11-02 · Filed 2019-02-21
Floating · LIBOR | Fed Funds | Prime
unsecured
Credit
Amended and Restated Credit Agreement
Matures 2020-11-04 · Filed 2017-02-23
Floating · LIBOR | Fed Funds | Prime
Financial covenants
Limitation on Liens on Restricted Property
≤ 15% of Consolidated Net Tangible Assets
Aggregate amount of outstanding Debt secured by Liens on Restricted Property (not otherwise excluded or equally and ratably secured)
FIVE YEAR CREDIT AGREEMENT
Limitation on Liens (Basket)
≤ 15% of Consolidated Net Tangible Assets
Aggregate amount of outstanding Debt secured by Liens on Restricted Property (not otherwise permitted)
364-DAY CREDIT AGREEMENT
Limitation on Use of Proceeds for Margin Stock
≤ 25% of the value of assets
Value of assets subject to restrictions that are margin stock
364-DAY CREDIT AGREEMENT
Limitation on Liens (Unsecured Debt Threshold)
≤ 15% of Consolidated Net Tangible Assets
Aggregate amount of all outstanding Debt of the Borrower and its Principal Domestic Subsidiaries secured or evidenced by Liens on Restricted Property (not otherwise excluded or equally and ratably secured)
364-DAY CREDIT AGREEMENT
Maximum Secured Debt on Restricted Property
≤ 15% of Consolidated Net Tangible Assets
Aggregate amount of all outstanding Debt of the Borrower and its Principal Domestic Subsidiaries secured or evidenced by Liens on Restricted Property (not otherwise excluded)
FIVE YEAR CREDIT AGREEMENT
Maximum Margin Stock as Percentage of Assets
≤ 25% will be margin stock
Value of assets of the Borrower (or Borrowing Subsidiary) and its Subsidiaries on a consolidated basis which are subject to restrictions of Section 5.02(a) or other debt agreements
FIVE YEAR CREDIT AGREEMENT
Cross-default risk
4 agreements contain cross-default provisions — a covenant breach on one facility may trigger default on others.
Xavier risk radar
Pro
Covenant headroom
High leverage — no covenants on file
Earnings quality
High quality (cash conversion 2.0x)
Risk trend
Risk increasing — Uncertain global macroeconomic conditions, geopolitical events and tensions, and
Mgmt narrative
Management tone: Cautiously optimistic
Analyst drift
Consensus Buy — targets stable
Insider sentiment
Pattern detection — 90 days needed
Signal history
Signal
DateDirectionConf.Agree.ThesisPriceType
Jun 07, 2026 NEUTRAL 6.2/10 100% CL bounced 4.1% today from ~$85 to $88.58 on no fresh fundamental catalyst — the Q1 2026 beat was re... $88.58 Sched.
May 31, 2026 NEUTRAL 6.2/10 100% CL is a high-quality defensive compounder, but at a ~35x TTM P/E with earnings growth effectively fl... $90.13 Sched.
May 24, 2026 NEUTRAL 5.8/10 100% CL's Q1 2026 beat (EPS $0.97 vs. $0.94 consensus, revenue $5.32B vs. $5.22B expected) is already ful... $90.61 Sched.
May 17, 2026 NEUTRAL 6.3/10 100% CL is a high-quality defensive name that beat Q1 2026 top and bottom-line estimates, but the post-ea... $88.13 Sched.
May 10, 2026 NEUTRAL 6.4/10 100% CL has defensive qualities and benefits from a supportive bullish macro backdrop, but the stock stil... $87.55 Sched.
May 03, 2026 NEUTRAL 6.4/10 75% CL just delivered a clean Q1 2026 beat ($0.97 adj. EPS vs. $0.95 est.; $5.32B revenue vs. $5.22B est... $87.26 Sched.
Apr 12, 2026 NEUTRAL 5.2/10 100% CL sits roughly 15% below its 52-week high and trades at a forward P/E of ~20.5x, a premium to its h... $84.34 Sched.
Showing last 7 signals
CL Colgate-Palmolive Company
Signal
FY2026 annual report (10-K filed 2026-02-23)
INCOME STATEMENT
? Revenue
$20,382 million 1.4% YoY
? Operating income
$3,306 million
? Net income
$2,132 million
? Free cash flow
$3,634 million
? EPS (diluted)
$0.80
? Dividend per share
$2.08
Click any row to expand the plain-English explanation. Source: SEC EDGAR XBRL filings.
Capital intelligence
Signal
Weighted Average Cost of Capital · Return on Invested Capital · Economic Value Added
ROIC
34.28%
WACC
5.48%
🟢 VALUE CREATOR — EVA Spread: 28.80%
? WACC
5.48%
? Cost of equity
6.00%
? Cost of debt (after-tax)
0.66%
? Capital structure
E: 90.17% / D: 9.83%
? ROIC
34.28%
? EVA
$1.9B
? NOPAT
$2.3B
Risk-free rate: 4.25% (10Y Treasury) · Equity risk premium: 5.50% · Sources: total_debt: XBRL, operating_income: XBRL TTM (4Q sum), interest_expense: Derived (OI - PTI), invested_capital: Equity + Debt - Cash
Xavier consensus signals are intelligence outputs, not investment advice. All signals are generated by a multi-model AI system and reflect public information at time of generation. Past signal accuracy does not guarantee future performance. Wall Street analyst consensus sourced from public disclosures, summarized weekly. Financial data sourced from SEC EDGAR and yfinance. Insider transactions sourced from SEC EDGAR Form 4 filings. Updated Jun 07, 2026.